Viewing Study NCT05234905


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-01-01 @ 3:52 AM
Study NCT ID: NCT05234905
Status: UNKNOWN
Last Update Posted: 2022-02-10
First Post: 2022-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: H101 Combined With Camrelizumab for Recurrent Cervical Cancer
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module